Contravisory Investment Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-23,668
Closed -$277K – 360
2023
Q1
$277K Sell
23,668
-350
-1% -$5.11K 0.08% 168
2022
Q4
$404K Buy
24,018
+3,934
+20% +$64.9K 0.11% 120
2022
Q3
$235K Hold
20,084
– – 0.08% 161
2022
Q2
$317K Hold
20,084
– – 0.1% 136
2022
Q1
$311K Sell
20,084
-3,999
-17% -$50.5K 0.09% 153
2021
Q4
$204K Buy
24,083
+3,934
+20% +$33.9K 0.06% 185
2021
Q3
$181K Buy
+20,149
New +$163K 0.06% 182

Other funds holding PTEN

Contravisory Investment Management's PTEN Position: Q2 2023 in Review

Contravisory Investment Management sold out of Patterson-UTI (PTEN) in Q2 2023, closing a stake of 23,668 shares — an estimated $277K sold.

Contravisory Investment Management first reported a position in PTEN in Q3 2021 and held it in 7 quarters. The position peaked at $404K in Q4 2022. 283 funds tracked by Wall St. Rank hold PTEN as of Q2 2023.

  • Contravisory Investment Management reported no remaining Patterson-UTI position as of Q2 2023 after selling out during the quarter.
  • Contravisory Investment Management sold 23,668 Patterson-UTI shares in Q2 2023, an estimated $277K.
  • Contravisory Investment Management first reported a position in Patterson-UTI in Q3 2021 and held it in 7 quarters.
  • Contravisory Investment Management's Patterson-UTI position peaked at $404K in Q4 2022.
  • 283 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2023.

Based on Contravisory Investment Management's 13F filing for Q2 2023, filed 12 Jul 2023.